CoreyAllanCarterMD(He/Him)

Oncology • South San Francisco, CA

Genitourinary Oncology, Melanoma, Thoracic Cancer

Global Development Leader GU

Join to view full profile

Dr. Carter is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Carter's full profile

Already have an account?

Office
1 Dna Way
South San Francisco, CA 94080
Phone+1 240-408-0425
Is this information wrong?

Education & Training

National Capital ConsortiumFellowship, Hematology and Medical Oncology, 2006 - 2009
UniforMed Services University of the Health Sciences F. Edward Hebert School of MedicineClass of 2003

Certifications & Licensure

VA State Medical License 2004 - 2026

Clinical Trials

A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer Start of enrollment: 2014 Oct 03
Active, not recruiting
Phase 3
Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
Completed
Phase 2
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
Completed
Phase 2, Phase 3
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

5 citations
A Phase 1b/2 Study of Atezolizumab with or Without Bacille Calmette-Guérin in Patients with High-risk Non-muscle-invasive Bladder Cancer.
Brant A Inman, Noah M Hahn, Kelly Stratton, Ryan Kopp, Alex Sankin, Eila Skinner, Kamal Pohar, Benjamin A Gartrell, Song Pham, Deepali Rishipathak, Sanjeev Mariathasan...> ;European Urology Oncology. 2023 Jun 1
3 citations
Comparative study of survival among small cell lung cancer patients in the U.S. military health system and those in the surveillance, epidemiology, and end results (SE...
Jie Lin, Christine Kamamia, Derek Brown, Stephanie Shao, Katherine A. McGlynn, Joel A. Nations, Corey A. Carter, Craig D. Shriver, Kangmin Zhu> ;Annals of Epidemiology. 2021 Sep 18
6 citations
Rationale and necessity for delivery of RRx-001, a Myc and CD47 antagonist, by intravenous blood mix.
Scott Caroen, Bryan Oronsky, Corey A. Carter, Michelle Lybeck, Arnold L. Oronsky, Tony R. Reid> ;Expert Opinion on Drug Delivery. 2020 Apr 30
90 citations
TGF-beta: a master immune regulator.
Christopher A. Larson, Bryan Oronsky, Corey A. Carter, Arnold L. Oronsky, Susan J. Knox, David J. Sher, Tony R. Reid> ;Expert Opinion on Therapeutic Targets. 2020 Apr 12
7 citations
RRx-001, a first-in-class small molecule inhibitor of MYC and a downregulator of CD47, is an "erythrophagoimmunotherapeutic".
Bryan Oronsky, Corey A. Carter, Scott Caroen, Curtis Scribner, Arnold L. Oronsky, Tony R. Reid> ;Oncoimmunology. 2020 Apr 3
40 citations
Just eat it: A review of CD47 and SIRP-α antagonism.
Bryan Oronsky, Corey A. Carter, Tony R. Reid, Franck Brinkhaus, Susan J. Knox> ;Seminars in Oncology. 2020 Apr 1
8 citations
Extended treatment with MY-NEOVAX, personalized neoantigen-enhanced oncolytic viruses, for two end-stage cancer patients.
Michael Bouvet, Tony R. Reid, Christopher A. Larson, Bryan Oronsky, Corey A. Carter, John C. Morris> ;Oxford Medical Case Reports. 2019 Nov 1
36 citations
REPLATINUM Phase III randomized study: RRx-001 + platinum doublet versus platinum doublet in third-line small cell lung cancer.
Bryan Oronsky, Tony R. Reid, Christopher A. Larson, Scott Caroen, Mary Flanagan Quinn, Erica Burbano, Gina Varner, Bennett Thilagar, Bradley Brown, Angelique Coyle, Li...> ;Future Oncology. 2019 Sep 11
9 citations
Cardioprotective Effect of Phase 3 Clinical Anticancer Agent, RRx-001, in Doxorubicin-Induced Acute Cardiotoxicity in Mice.
Bryan T. Oronsky, Eilleen S. Y. Ao-ieong, Ozlem Yalcin, Corey Carter, Pedro Cabrales> ;Molecular Pharmaceutics. 2019 Apr 30
72 citations
APOBEC Mutagenesis and Copy-Number Alterations Are Drivers of Proteogenomic Tumor Evolution and Heterogeneity in Metastatic Thoracic Tumors
Nitin Roper, Shaojian Gao, Tapan K. Maity, A. Rouf Banday, Xu Zhang, Abhilash Venugopalan, Constance M. Cultraro, Rajesh Patidar, Sivasish Sindiri, Anna-Leigh Brown, A...> ;Cell Reports. 2019 Mar 5
6 citations
A practical guide to the handling and administration of personalized transcriptionally attenuated oncolytic adenoviruses (PTAVs).
Christopher A. Larson, Bryan Oronsky, Gina Varner, Scott Caroen, Erica Burbano, Elisa Insel, Farah Hedjran, Corey A. Carter, Tony R. Reid> ;Oncoimmunology. 2018 Jul 23
6 citations
Case Series: Abscopal Benefit of Surgery in 3 Immunotherapy-Treated Patients With Unresectable Cancer:
Bryan Oronsky, Christopher A. Larson, Tony R. Reid, Corey A. Carter> ;Journal of Investigative Medicine High Impact Case Reports. 2018 Jul 6
48 citations
A Review of Clinical Radioprotection and Chemoprotection for Oral Mucositis.
Bryan Oronsky, Sharad Goyal, Michelle M. Kim, Pedro Cabrales, Michelle Lybeck, Scott Caroen, Neil Oronsky, Erica Burbano, Corey A. Carter, Arnold L. Oronsky> ;Translational Oncology. 2018 Jun 1
15 citations
Brief report: RRx-001 is a c-Myc inhibitor that targets cancer stem cells.
Bryan Oronsky, Tony R. Reid, Arnold L. Oronsky, Scott Caroen, Corey A. Carter, Pedro Cabrales> ;Oncotarget. 2018 May 4
18 citations
Survival among Lung Cancer Patients in the U.S. Military Health System: A Comparison with the SEER Population
Jie Lin, Christine Kamamia, Derek Brown, Stephanie Shao, Katherine A. McGlynn, Joel A. Nations, Corey A. Carter, Craig D. Shriver, Kangmin Zhu> ;Cancer Epidemiology, Biomarkers & Prevention. 2018 Jan 1
21 citations
Navigating the “No Man's Land” of TKI-Failed EGFR-Mutated Non–Small Cell Lung Cancer (NSCLC): A Review
Bryan Oronsky, Patrick C. Ma, Tony R. Reid, Pedro Cabrales, Michelle Lybeck, Arnold L. Oronsky, Neil Oronsky, Corey A. Carter> ;Neoplasia. 2018 Jan 1
382 citations
Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas
Bryan Oronsky, Patrick C. Ma, Daniel Morgensztern, Corey A. Carter> ;Neoplasia. 2017 Dec 1
113 citations
What's New in SCLC? A Review
Bryan Oronsky, Tony R. Reid, Arnold L. Oronsky, Corey A. Carter> ;Neoplasia. 2017 Oct 1
54 citations
Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management.
Bryan Oronsky, Scott Caroen, Arnold L. Oronsky, Vaughn E. Dobalian, Neil Oronsky, Michelle Lybeck, Tony R. Reid, Corey A. Carter> ;Cancer Chemotherapy and Pharmacology. 2017 Jul 20
29 citations
Metformin use and survival after non‐small cell lung cancer: A cohort study in the US Military health system
Jie Lin, Abegail A. Gill, Shelia Hoar Zahm, Corey A. Carter, Craig D. Shriver, Joel A. Nations, William F. Anderson, Katherine A. McGlynn, Kangmin Zhu> ;International Journal of Cancer. 2017 Jul 15
111 citations
A brief review of the management of platinum-resistant-platinum-refractory ovarian cancer.
Bryan Oronsky, Carolyn M. Ray, Alexander I. Spira, Jane B. Trepel, Corey A. Carter, Hope M. Cottrill> ;Medical Oncology. 2017 Apr 25
16 citations
RRx-001 protects against cisplatin-induced toxicities
Bryan Oronsky, Tony R. Reid, Christopher A. Larson, Corey A. Carter, Christina Brzezniak, Arnold L. Oronsky, Pedro Cabrales> ;Journal of Cancer Research and Clinical Oncology. 2017 Apr 17
3 citations
A Case of Paraneoplastic Cushing Syndrome Presenting as Hyperglycemic Hyperosmolar Nonketotic Syndrome.
Christina Brzezniak, Nicole Vietor, Patricia E Hogan, Bryan Oronsky, Bennett Thilagar, Carolyn M. Ray, Scott Caroen, Michelle Lybeck, Neil Oronsky, Corey A. Carter> ;Case Reports in Oncology. 2017 Jan 1
9 citations
No patient left behind: The promise of immune priming with epigenetic agents.
Corey A. Carter, Bryan Oronsky, Joseph Roswarski, Arnold L. Oronsky, Neil Oronsky, Jan Scicinski, H. Lybeck, Michelle M. Kim, Michelle Lybeck, Tony R. Reid> ;Oncoimmunology. 2017 Aug 30
3 citations
Superior Vena Cava Syndrome in a Patient with Small-Cell Lung Cancer: A Case Report.
Christina Brzezniak, Bryan Oronsky, Corey A. Carter, Bennett Thilagar, Scott Caroen, Karen Zeman> ;Case Reports in Oncology. 2017 Jan 1
Join now to see all

Press Mentions

EpicentRx Appoints Senior Life Science Financial Executive Dr. Franck BrinkhausDecember 4th, 2019
EpicentRx Initiates Dosing in Phase 3 Trial of Immunotherapy RRx-001 for Third-Line Small Cell Lung CancerNovember 5th, 2019